Literature DB >> 21278712

Predialysis chronic kidney disease in 2010: Novel targets for slowing CKD progression.

Juan Jesús Carrero1, Peter Stenvinkel.   

Abstract

Several 2010 trials have provided novel information on how best to manage patients with predialysis chronic kidney disease (CKD). Armed with these new findings, nephrologists can find new means of slowing CKD progression by targeting blood-pressure control, acidosis and serum uric acid levels.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21278712     DOI： 10.1038/nrneph.2010.177

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  9 in total

1.  Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.

Authors:  Marian Goicoechea; Soledad García de Vinuesa; Ursula Verdalles; Caridad Ruiz-Caro; Jara Ampuero; Abraham Rincón; David Arroyo; José Luño
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 8.237

2.  Association of uric acid with change in kidney function in healthy normotensive individuals.

Authors:  Gianni Bellomo; Sandro Venanzi; Claudio Verdura; Paolo Saronio; Antonella Esposito; Mario Timio
Journal:  Am J Kidney Dis       Date:  2010-04-10       Impact factor: 8.860

3.  Intensive blood-pressure control in hypertensive chronic kidney disease.

Authors:  Lawrence J Appel; Jackson T Wright; Tom Greene; Lawrence Y Agodoa; Brad C Astor; George L Bakris; William H Cleveland; Jeanne Charleston; Gabriel Contreras; Marquetta L Faulkner; Francis B Gabbai; Jennifer J Gassman; Lee A Hebert; Kenneth A Jamerson; Joel D Kopple; John W Kusek; James P Lash; Janice P Lea; Julia B Lewis; Michael S Lipkowitz; Shaul G Massry; Edgar R Miller; Keith Norris; Robert A Phillips; Velvie A Pogue; Otelio S Randall; Stephen G Rostand; Miroslaw J Smogorzewski; Robert D Toto; Xuelei Wang
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

Review 4.  Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal.

Authors:  Juan Jesús Carrero; Peter Stenvinkel
Journal:  Clin J Am Soc Nephrol       Date:  2009-12       Impact factor: 8.237

5.  Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial.

Authors:  Paul M Ridker; Jean MacFadyen; Michael Cressman; Robert J Glynn
Journal:  J Am Coll Cardiol       Date:  2010-03-04       Impact factor: 24.094

6.  Is high serum uric acid a risk marker or a target for treatment? Examination of its independent effect in a large cohort with low cardiovascular risk.

Authors:  Chi Pang Wen; Ting-Yuan David Cheng; Hui Ting Chan; Min Kuang Tsai; Wen-Shen Isabella Chung; Shan Pou Tsai; Mark L Wahlqvist; Yi Chen Yang; Shiuan Be Wu; Po Huang Chiang; Sung Feng Wen
Journal:  Am J Kidney Dis       Date:  2010-06-03       Impact factor: 8.860

7.  Serum bicarbonate and long-term outcomes in CKD.

Authors:  Vandana Menon; Hocine Tighiouart; Nubia Smith Vaughn; Gerald J Beck; John W Kusek; Allan J Collins; Tom Greene; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2010-06-03       Impact factor: 8.860

8.  Bicarbonate supplementation slows progression of CKD and improves nutritional status.

Authors:  Ione de Brito-Ashurst; Mira Varagunam; Martin J Raftery; Muhammad M Yaqoob
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

9.  Uric acid and long-term outcomes in CKD.

Authors:  Magdalena Madero; Mark J Sarnak; Xuelei Wang; Tom Greene; Gerald J Beck; John W Kusek; Allan J Collins; Andrew S Levey; Vandana Menon
Journal:  Am J Kidney Dis       Date:  2009-03-20       Impact factor: 8.860
  9 in total
  2 in total

1.  Hypertension and hyperglycemia synergize to cause incipient renal tubular alterations resulting in increased NGAL urinary excretion in rats.

Authors:  Ana M Blázquez-Medela; Omar García-Sánchez; Víctor Blanco-Gozalo; Yaremi Quiros; María J Montero; Carlos Martínez-Salgado; José M López-Novoa; Francisco J López-Hernández
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

2.  Multidisciplinary care for poor patients with chronic kidney disease in Mexico.

Authors:  Guillermo Garcia-Garcia; Yolanda Martinez-Castellanos; Karina Renoirte-Lopez; Alberto Barajas-Murguia; Librado de la Torre-Campos; Laura E Becerra-Muñoz; Jaime A Gonzalez-Alvarez; Marcello Tonelli
Journal:  Kidney Int Suppl (2011)       Date:  2013-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.